Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Centrally selective nAChR ligand from R.J. Reynolds considered Alzheimer's disease candidate

Nov. 9, 1998

Selective M2 receptor antagonist from Schering-Plough with potential in AD

Nov. 9, 1998

Novel 5-HT1B receptor antagonist presented this week by Astra Arcus

Nov. 9, 1998

Pfizer prepares metabolically stable adamantane derivatives

Nov. 9, 1998

Kyowa Hakko patents new adenosine A2A antagonists

Nov. 9, 1998

Pyrazolopyrimidines useful as analgesics prepared at Otsuka

Nov. 9, 1998

FDA approves Actiq for treatment of breakthrough cancer pain

Nov. 6, 1998

Gliatech's first drug candidate begins phase I clinical trials

Nov. 6, 1998

SIB-1508Y demonstrates neuroprotective effects in rat model of PD

Nov. 6, 1998

CPMP votes against approval recommendation for propentofylline

Nov. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...